UNDERVALUED PENNY STOCKS

[iancnyc]

NNRX ALL-IN-ONE DUE DILIGENCE

October 1, 2015, Dr. Joe Eyring, the new CEO, came on board.
http://ih.advfn.com/p.php?pid=nmona&article=68767027

October 14, 2015, Dr. Joe Eyring issued Shareholder Letter.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117705371

Revenues for the first 9 months were $1,345,110 with Gross Profits were $685,731.
http://ih.advfn.com/p.php?pid=nmona&article=67719385

The bottom line will look even better in the future with cost cutting measures:

"The day I assumed office, I dismissed underperforming staff, began scripting an employee handbook, defined job requirements and reviewed the balance of W-2 versus 1099 staff. In the weeks after, we audited our supply chain, manufacturing, inventory, pricing and reviewed credit lines for customers and our own with our creditors and banks. We cut, trimmed, streamlined and found savings never before realized. Our work resulted in significant reductions of operating costs, and in one such case, we found an available cost reduction of 30% on our leading products. We expect to realize these financial benefits and others in the coming quarters."

GenEpic PBS Special & Other Links
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118032527

NNRX's Products Can Be Bought Here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118032561

Future News to look forward to:

1) Dr. Joe Eyring to inject his own money into NNRX. This could come out at any moment now.

"We qualified and quantified each of the financings which may have dilutive effects in the future. I say "may" because it is our intent to pay them off if possible, all of them, with capital I plan to personally inject into NNRX in the coming weeks. I cannot disclose more of these details but certainly will in an 8-K and press release as appropriate."

2) Sale orders News coming out of Asia.

"We negotiated an exclusive worldwide license for GenEpic® and refocused Dr. Gibbs onto OEM and formulation sales. At this moment, Dr. Gibbs is in Asia actively securing orders for our OEM and Formulation Division."

Pictures of Dr. Gibbs currently in Japan
https://www.facebook.com/GenEpic.in.Japan/photos_stream

3) Distribution deals to bring NNRX's products to local and national retail chains.

4) Updates on Cancer treatments.
https://www.facebook.com/Nutranomicsinc

Share Structure from TA
A/S = 750,000,000
O/S = 481,780,758
Float = 380,000,000 (Dr. Gibbs' and former CEO's funds hold almost 100,000,000)